arrow
C

Christoph Rochlitz

university of basel
H指数:44
被引数:9,077

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancer
2023-03-0621
OAAI
Eribulin as first-line treatment in older patients with advanced breast cancer: A multicenter phase II trial [SAKK 25/14]
2023-01-011
OA
An In Vivo CRISPR Screen Identifies Stepwise Genetic Dependencies of Metastatic Progression
2021-12-1617
OAAI
Anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple-negative, EGFR positive breast cancer: A multicenter single arm phase II trial [SAKK 24/14]
2021-09-013
OA
Hypoxia Triggers the Intravasation of Clustered Circulating Tumor Cells
2020-09-01148
OAAI
Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10)
2017-04-1313
OAAI
SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial
2016-10-1042
OAAI